Article
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.
Proceedings of the National Academy of Sciences of the United States of America - 25 Jan 2011
Cantor Jason R, Yoo Tae Hyeon, Dixit Aakanksha, Iverson Brent L, Forsthuber Thomas G, Georgiou George
Abstract excerpt
A number of heterologous enzymes have been investigated for cancer treatment and other therapeutic applications; however, immunogenicity issues have limited their clinical utility. Here, a new approach has been created for heterologous enzyme deimmunization whereby combinatorial saturation mutagenesis is coupled with a screening strategy that capitalizes on the evolutionary biology concept of neutral drift, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
